FE ATURES
GROUNDBREAKING CAR-T CELL THERAPY ARRIVES
AT PENN STATE CANCER INSTITUTE 05
Adult patients with lymphoma who have exhausted other
treatment options can receive leading-edge CA R-T cell
therapy, which uses their own T cells to combat their cancer.
SETTING THE STANDARD FOR EXERCISE
ONCOLOGY 08
Penn State Cancer Institute has built on its reputation
for advanced care by developing a program leveraging the
documented benefits of exercise for cancer patients.
LIVER CANCER PATIENTS HAVE LOCAL ACCESS
TO MINIMALLY INVASIVE, LIFE-EXTENDING
TREATMENT AT PENN STATE HEALTH
ST. JOSEPH CANCER CENTER
10
For many patients with liver cancer, y ttrium-90 selective
interna l radiation therapy, in combination with conventiona l
treatments, generates markedly improved outcomes.
05
contents
ON THE COVER
/////// OCT 2018
SPECIAL CLINICAL SECTION: ONCOLOGY
THIRDHAND SMOKE EXPOSURE MAY INCREASE
LUNG CANCER RISK, RESEARCHERS FIND 13
A study on mice suggests there are substantia l long-term risks
from thirdhand smoke.
STUDY SHOWS SURVIVAL ADVANTAGE FOR
CERTAIN LEUKEMIA PATIENTS TREATED IN
PEDIATRIC CANCER CENTERS 14
Surviva l among adolescents and young adults with acute
lymphoblastic leukemia varies significantly by care setting.
DEPARTMENTS
DATA VAULT 02
PRACTICE MANAGEMENT 09
PRODUCT SPOTLIGHT 11
08
10
